Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
about
Drug therapy in cardiac arrest: a review of the literatureSuccessful alteplase bolus administration for a presumed massive pulmonary embolism during cardiopulmonary resuscitation.Role of thrombolytic agents in cardiac arrest.Impact of rescue-thrombolysis during cardiopulmonary resuscitation in patients with pulmonary embolismThrombolytics for cardiac arrest: case report and systematic review of controlled trials.Prolonged chest compressions during cardiopulmonary resuscitation for in-hospital cardiac arrest due to acute pulmonary embolism.Current pharmacological advances in the treatment of cardiac arrest.Responses to written notification during out-of-hospital care trials using waiver of informed consent.Thromboelastometric analysis of the risk factors for return of spontaneous circulation in adult patients with out-of-hospital cardiac arrestThrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor.Comparing percutaneous coronary intervention and thrombolysis in patients with return of spontaneous circulation after cardiac arrest.Outcome of out-of-hospital cardiac arrest after fibrinolysis with reteplase in comparison to the return of spontaneous circulation after cardiac arrest score in a geographic region without emergency coronary interventionA case of survival after cardiac arrest and 3½ hours of resuscitation.Thrombin-antithrombin appearance in out-of-hospital cardiac arrest.Double Bolus Thrombolysis for Suspected Massive Pulmonary Embolism during Cardiac ArrestCoagulofibrinolytic Changes in Patients with Post-cardiac Arrest Syndrome.Impact of fibrinolysis on immediate prognosis of patients with out-of-hospital cardiac arrest.[Inhospital resuscitation : Decisive measures for the outcome].Double Bolus Alteplase Therapy during Cardiopulmonary Resuscitation for Cardiac Arrest due to Massive Pulmonary Embolism Guided by Focused Bedside Echocardiography.
P2860
Q26741074-1A6C4AF9-143D-4563-9223-851867A31D91Q33163538-23E0EB08-249A-49B3-AFEB-98660657407AQ33258227-8C569A4A-4BDE-4061-AE17-9F51944A18B1Q33519050-46E32336-0A85-434D-9DF5-6ECA87CE53EFQ34152545-04DFCFF1-61BC-472A-BEEB-AAF2CC108424Q35246237-E4AD1F8A-2663-411C-AB54-B432F017D637Q35579483-76DC0168-A783-4BA4-A052-4B730C03F292Q36303610-35378CD3-330D-4098-90B6-C750FFC3ED41Q36335991-5D06B204-DD41-4724-872C-9906A2CC97C7Q36541269-D9F740C4-14D7-4EC1-8AFA-5F969967CE04Q36791681-97851660-7183-4030-B3E3-A48EA3094ECEQ37734973-F80AD4A7-081F-4431-B515-66B7D16530BDQ39055041-EFBA5E6D-9443-42F3-845F-23B31C1C4790Q39778660-75AED6F4-0693-43AD-ADF7-0F204CFD15F4Q41877540-224000EB-54BE-4C20-84F1-386F3FE21D68Q42369766-8E2E0A84-1ADD-44EA-A5A9-35B1730B029DQ47788625-BC52482A-A46C-42A8-9E50-D5D1FFF48A6CQ53535174-FFD35614-CE71-4039-B604-D4D7FC79838BQ54961860-A4BF6ED4-373E-4042-8ACE-590F3BCAC8FE
P2860
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
description
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2002
@uk
name
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
@en
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
@nl
type
label
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
@en
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
@nl
prefLabel
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
@en
Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity
@nl
P2093
P356
P1476
Tissue plasminogen activator in cardiac arrest with pulseless electrical activity
@en
P2093
Catherina A van Beek
Grant D Innes
Iain A MacPhail
James M Christenson
Joe Puskaric
Joel Singer
Karen P Wanger
R Douglas McKnight
Richard P Sadowski
Riyad B Abu-Laban
P304
P356
10.1056/NEJMOA012885
P407
P577
2002-05-01T00:00:00Z